Predictors of early immunotherapy response in head and neck cancer: Per lesion analysis of a prospective randomized trial with nivolumab.
Yu Y, Chen L, Riaz N, Kang J, Tsai C, Sherman E, Lee N, McBride S. Predictors of early immunotherapy response in head and neck cancer: Per lesion analysis of a prospective randomized trial with nivolumab. Journal Of Clinical Oncology 2019, 37: 6041-6041. DOI: 10.1200/jco.2019.37.15_suppl.6041.Peer-Reviewed Original ResearchNon-irradiated lesionsOral cavity primariesRisk of progressionNeck cancerExact testLogistic regressionNeck primary sitePrimary tumor subsiteTrials of nivolumabPD-L1 statusLymph node metastasisMultivariate logistic regressionPredictors of responsePrimary tumor siteStereotactic body radiotherapyFisher's exact testElicit clinical responsesStable diseaseCheckpoint inhibitorsMetastatic headClinical responseFirst doseLiver metastasesMetastasis locationProgressive diseaseTrends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14)
Lee A, Kang J, Yu Y, McBride S, Riaz N, Cohen M, Sherman E, Michel L, Lee N, Tsai CJ. Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14). International Journal Of Particle Therapy 2019, 5: 1-10. PMID: 31773036, PMCID: PMC6871620, DOI: 10.14338/ijpt-19-00051.1.Peer-Reviewed Original ResearchNational Cancer DatabasePrimary disease siteMultivariable logistic regressionTherapy useNeck cancerRadiation therapyCancer DatabasePrimary siteDisease sitesNasal cavity/nasopharynxLogistic regressionInitial treatment courseNeck primary malignancyProton therapyCommon primary siteDistribution of patientsHousehold income quartileT4 diseaseMost patientsPrimary malignancyClinical factorsNonmetastatic headTreatment coursePrimary headOral cavity